0001179110-18-013337.txt : 20181130
0001179110-18-013337.hdr.sgml : 20181130
20181130172232
ACCESSION NUMBER: 0001179110-18-013337
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181129
FILED AS OF DATE: 20181130
DATE AS OF CHANGE: 20181130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gosebruch Henry O
CENTRAL INDEX KEY: 0001659625
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 181212051
MAIL ADDRESS:
STREET 1: 1 N. WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064-6092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
4
1
edgar.xml
FORM 4 -
X0306
4
2018-11-29
0
0001551152
AbbVie Inc.
ABBV
0001659625
Gosebruch Henry O
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
0
1
0
0
EVP, Chief Strategy Officer
Common stock, $0.01 par value
2018-11-29
4
S
0
42450
90.1046
D
30350
D
Common stock, $0.01 par value
1807
I
Profit sharing trust
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.24, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Balance in AbbVie Savings program as of November 30, 2018.
The transactions reported on this Form 4 were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
Steven L. Scrogham, attorney-in-fact for Henry O. Gosebruch
2018-11-30